Duodenum-triggered delivery of pravastatin sodium: II. Design, appraisal and pharmacokinetic assessments of enteric surface-decorated nanocubosomal dispersions

Autor: Mina Ibrahim Tadros, Mohamed A. El-Nabarawi, Saadia A. Tayel, Wessam H. Abd-Elsalam
Rok vydání: 2016
Předmět:
Zdroj: Drug Delivery. 23:3266-3278
ISSN: 1521-0464
1071-7544
DOI: 10.3109/10717544.2016.1172367
Popis: Pravastatin sodium (PVS) is a freely water-soluble HMG-CoA inhibitor that suffers from instability at gastric pH, extensive first pass metabolism, short elimination half-life (1-3 h) and low oral bioavailability (18%).To overpower these drawbacks and to maximize drug absorption at its main site of absorption at the duodenum, enteric surface-coated PVS-loaded nanocubosomal dispersions were presented.Glyceryl monooleate (GMO)-based dispersions were developed by the fragmentation or the liquid precursor methods using Pluronic® F127 or Cremophor® EL as surfactants. As a challenging enteric-coating approach, the promising dispersions were surface-coated via lyophilization with Eudragit® L100-55; a duodenum-targeting polymer. The drug content, particle size, zeta potential, morphology and release studies of PVS-loaded dispersions were evaluated before and after surface-coating. Compared to an aqueous PVS solution, the pharmacokinetics of the best achieved system (E-F8) was evaluated (UPLC-MS/MS) in rats.The enteric surface-coated nanocubosomal dispersions were more or less spherical in shape and showed high drug-loading, negative zeta potential values and fine-tuned biphasic drug-release patterns characterized by retarded (2 h) and sustained (10 h) phases in pH 1.2 and pH 6.8, respectively. E-F8 system showed significantly (p 0.05) higher oral bioavailability, delayed TThe duodenum-triggering potential and the controlled-release characteristics of the best achieved system for smart PVS delivery were revealed.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje